Navigation Links
Unibioscreen and Drais Pharmaceuticals Partner to Develop and Commercialize UNBS 5162 for Treatment of Cancer
Date:9/15/2008

BRIDGEWATER, N.J., and BRUSSELS, Belgium, Sept. 15 /PRNewswire/ -- Drais Pharmaceuticals, Inc. and Unibioscreen S.A. today announced that they have entered into a global agreement to develop and commercialize UNBS 5162, one of Unibioscreen's investigational drug and potential breakthrough treatments for cancer. UNBS 5162 was discovered by Unibioscreen and is currently in Phase I trials in the United States in cancer patients with advanced solid tumors or lymphoma.

"This is an important milestone for Drais as we focus on building a portfolio of novel therapeutics," said Dr. Donna L. Tempel, president and chief executive officer of Drais Pharmaceuticals. "Partnering with innovative companies like Unibioscreen is an important step towards implementing our strategy of in-licensing and developing novel therapeutic treatments that meet unmet medical needs."

Under the terms of the agreement, Unibioscreen will receive upfront, development and regulatory milestones payments up to $31 million, in addition to commercial milestone payments. The license grants exclusive rights to Drais to develop and commercialize UNBS 5162 worldwide.

Christiane Verhaegen, chief executive officer and chief financial officer of Unibioscreen commented: "Unibioscreen's deal with Drais is a key milestone for both the development of the drug candidate and for the company as it provides validation of Unibioscreen's promising pipeline of potential cancer treatments in addition to monetary benefits. We are confident that Drais' experienced team will maximize the progression of UNBS 5162 and believe this agreement will provide excellent value for both partners." Denis Biju-Duval, Head of ING Belgium Corporate Investments added: "The agreement illustrates the ability of Unibioscreen to successfully exploit its unique technology and know-how. Unibioscreen will continue to innovate in the oncology sector."

About UNBS 5162

UNBS 5162 is a novel anti-cancer naphthalimi
'/>"/>

SOURCE Drais Pharmaceuticals, Inc. and Unibioscreen S.A.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vanda Pharmaceuticals Provides Update on Iloperidone
2. Cerimon Pharmaceuticals Announces Positive Results from a Phase II Clinical Study of Its Diclofenac Sodium Patch for Acute Pain
3. Jazz Pharmaceuticals, Inc. Announces Final Patient Has Completed Phase III Clinical Trial of Sodium Oxybate to Treat Fibromyalgia
4. Addrenex Pharmaceuticals Announces Positive Phase III Clinical Results for Clonicel to Treat ADHD
5. Celator Pharmaceuticals Receives Orphan Drug Designation for Anticancer Agent CPX-351
6. Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients
7. Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials
8. Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD)
9. Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies
10. Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial
11. Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)...  Numotion is pleased to announce the appointment of ... Mark is a 30-year retired veteran of GE ... organization and was a GE Company Officer since 1999 and ... years running business units within GE Healthcare, with the most ... "We are delighted to welcome Mark to our ...
(Date:9/2/2014)... NEW YORK , Sept. 2, 2014 ... available in its catalogue: Asia - ... http://www.reportlinker.com/p02353212/Asia---Pacific-Minimally-Invasive-Surgery-Spinal-Device-Market.html The growth rate ... MIS spinal device market will remain at double-digit levels ... spinal surgeries as the future of this field. The ...
(Date:9/2/2014)... Sept. 2, 2014 Depomed, Inc. (Nasdaq: ... offer, subject to market and other conditions, $230 million ... (the "Notes"). Depomed, Inc. ("Depomed") expects to grant the ... up to an additional $34.5 million aggregate principal amount ... RBC Capital Markets, LLC will act as joint book-running ...
Breaking Medicine Technology:Asia - Pacific Minimally Invasive Surgery Spinal Device Market 2Asia - Pacific Minimally Invasive Surgery Spinal Device Market 3Asia - Pacific Minimally Invasive Surgery Spinal Device Market 4Asia - Pacific Minimally Invasive Surgery Spinal Device Market 5Asia - Pacific Minimally Invasive Surgery Spinal Device Market 6Asia - Pacific Minimally Invasive Surgery Spinal Device Market 7Asia - Pacific Minimally Invasive Surgery Spinal Device Market 8Asia - Pacific Minimally Invasive Surgery Spinal Device Market 9Asia - Pacific Minimally Invasive Surgery Spinal Device Market 10Depomed Announces Offering of $230 Million Convertible Senior Notes Due 2021 2Depomed Announces Offering of $230 Million Convertible Senior Notes Due 2021 3
... Decision Resources, one of the world,s leading research ... that biosimilar insulins and insulin analogues stand to erode ... Europe (France, Germany, Italy, Spain and U.K.) by 2018, ... , As insulins are relatively easy to develop and ...
... Corporation (Nasdaq: SMTS ) today announced that it ... Partners II, LLC ("Raba coreFoundry"). Under terms of ... specified rights of the U.S. Government and rights retained ... technology developed at The Johns Hopkins University. Integration ...
Cached Medicine Technology:Biosimilar Insulins and Insulin Analogues Stand to Erode $6.1 Billion in Brand Sales in the U.S. and Europe by 2018 2Biosimilar Insulins and Insulin Analogues Stand to Erode $6.1 Billion in Brand Sales in the U.S. and Europe by 2018 3Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 2Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 3Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 4Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 5
(Date:9/2/2014)... Fla. (PRWEB) September 02, 2014 ... join together in Tampa Bay from September 4-6 ... annual Scientific Symposium and FARA Energy Ball Gala. ... USF Ataxia Research Center in their pursuit of ... affected by the progressive neuromuscular disease Friedreich’s ataxia ...
(Date:9/2/2014)... Los Angeles, CA (PRWEB) September 03, 2014 ... helps health enthusiasts, bodybuilders, and athletes obtain the ... announced its launch. The site, which focuses mainly ... is dedicated to helping individuals increase their workout ... to an article available on Top Creatine Monohydrate, ...
(Date:9/2/2014)... UWDress.com, an experienced supplier of wedding dresses and women’s ... bridesmaid dresses for 2014 to its product ... offer to celebrate the coming autumn. All clients can ... off. , The company’s sales representative says, “We ... dresses for consumers from every part of the world. ...
(Date:9/2/2014)... September 02, 2014 Becker's Healthcare ... Center Educational Program on October 23-25, 2014 at ... Annual Meeting - The Business and Operations of ... through high-quality continuing education, networking events, and an ... technologies. , Outstanding educational offerings throughout the three-day ...
(Date:9/2/2014)... Recently, BambooIndustry.com, an excellent company in the ... strand woven bamboo floors to celebrate the coming ... appreciation to the frequent callers, BambooIndustry.com launched a promotion ... to strand woven floors, BambooIndustry.com provides many kinds of ... click strand woven floors, click lock floors, wide plank ...
Breaking Medicine News(10 mins):Health News:Event Gathers World-Renowned Researchers and Community Leaders to Find a Cure for Rare Disease, Friedreich’s Ataxia 2Health News:Event Gathers World-Renowned Researchers and Community Leaders to Find a Cure for Rare Disease, Friedreich’s Ataxia 3Health News:Creatine Monohydrate Reviews Site TopCreatineMonohydrate.com Announces its Launch 2Health News:Elegant Bridesmaid Dresses For 2014, Latest Designs From UWDress.com 2Health News:Becker's Healthcare Announces Ambulatory Surgery Center Educational Program 2Health News:Becker's Healthcare Announces Ambulatory Surgery Center Educational Program 3Health News:Cheap Strand Woven Bamboo Floors For Autumn On Sale At BambooIndustry.com 2
... CIA Interrogation Tactics Confirms Severe and Long-Lasting Harm of Techniques ... ... 17, 2009 -- The newly released Bush Administration,s Office of ... involvement of health professionals in designing, supervising and implementing the ...
... Trauma Center and Neurological Intensive Care UnitATLANTA, April 17 ... gift to Grady Health System to improve emergency care ... The gift will enable Grady to expand hospital ... time-dependent therapies for stroke and acute neurological emergencies. ...
... SINGAPORE, April 17 /PRNewswire-Asia/ -- GfK Asia is pleased ... for the optical,industry today in line with the 14th ... to our recent survey in Malaysia, 25% of,consumers visit ... close to the,Asian average of 28%. "Despite the current ...
... cancer are well known, the risks they confer are ... access journal BMC Medicine describes the exact ... of colorectal cancer in a large group of patients. ... from the Universities of Bristol and Birmingham who studied ...
... Aurora Health Care ... replacement this morning. This first, in Wisconsin, ... reach thousands of viewers. (Photo: http://www.newscom.com/cgi-bin/prnh/20090416/CG00542 ... Aurora caregivers posted updates as "tweets" and answered ...
... SAN DIEGO, Calif., April 16 Join San Diego ... across the country, in making future healthcare decisions known ... Decisions Day is April 16. Now is a great ... directive, because... YOUR DECISIONS MATTER. What is ...
Cached Medicine News:Health News:OLC Memos Confirm Integral Role of Health Professionals in US Torture 2Health News:OLC Memos Confirm Integral Role of Health Professionals in US Torture 3Health News:The Marcus Foundation Gives $20 Million to Grady Health System 2Health News:The Marcus Foundation Gives $20 Million to Grady Health System 3Health News:GfK Asia Releases First Ever Malaysian Contact Lens Industry Retail Measurement 2Health News:GfK Asia Releases First Ever Malaysian Contact Lens Industry Retail Measurement 3Health News:Colorectal cancer risks quantified 2Health News:Aurora Health Care Twitter-Surgery A Success 2Health News:Your Decisions Matter: San Diego Hospice Encourages You to Make Your Healthcare Decisions Known 2
... Chrome-plated metal frames ... ensures optimal cleanliness and ... stools come with user-friendly ... height adjustment. Fixed footring ...
... The ideal modular cleanroom for ... applications that require cleanliness (to Class ... are precision-joined to create ultra-smooth surfaces ... and disinfect. One-inch radius corners simplify ...
... cleanroom for biological safety labs (BSL) ... (to Class 10/ISO 3) and easy ... ultra-smooth surfaces that are easy to ... corners simplify cleaning. Unique double-wall panel ...
Inquire...
Medicine Products: